Scholarly Sessions

Public Health

Developmental and Behavioral Pediatrics

Pharmacology

General Pediatrics

Clinical Research Pathway

Adolescent Medicine

Academic and Research Skills

Dangerous Drug Epidemic: Opioids, Vaping, and Cannabis

Chair(s)

• JV

  Janelle Vaughns, MD

  Associate Professor of Anesthesiology & Critical Care and Pediatrics
  Anesthesia
  Childrens National Health System
  Washington, District of Columbia, United States
• 

  Sonya Tang Girdwood, MD, PhD

  Assistant Professor
  Pediatrics
  Cincinnati Children's Hospital Medical Center
  Fort Thomas, Kentucky, United States

The dangers of opioid, vaping and cannabis consumption are ever present within the pediatric community. Current U.S. trends related to these substances reveal an alarming dependence and abuse potential for these drugs with lethal consequences. This session will consider and present: 1) the current status of the opioid crisis across pediatric population groups specifically focusing upon new and innovative technology that is able to detect drug withdrawal in neonatal abstinence syndrome (NAS) and analgesia, diversion or recreational use in children and adolescents; 2) describe the natural history of current use and disposition of medical cannabis products and understand the pharmacokinetic and pharmacodynamics of these products in pediatrics; 3) provide up-to-date regulatory data and information from the Food and Drug Administrative (FDA) concerning the agency’s actions and recommendations for the public regarding Electronic Nicotine Delivery Systems (ENDS) including vaporizers and e-cigarettes and 4) describe the health risks associated with the use of vaping, an evolving epidemic in children and adolescents. Session speakers are recognized experts in their respective fields, including academia and the FDA. The session will include an interactive panel discussion, designed to facilitate discussion of high-impact clinical questions and strategies with potential for multi-institutional collaboration. At the conclusion of this session, learners may participate in a discussion of research priorities, collaborative opportunities, and strategies for clinical implementation of the information presented in the symposium

Presentations:

• 4:30 PM - 4:35 PM US CT

  Chair and Submitter-Overview
  

  Presenter: Janelle Vaughns, MD – Childrens National Health System
• 4:35 PM - 4:55 PM US CT

  Development of a Non-invasive PD Biomarker of Opioids and Cannabis in Infants, Children and Adolescents
  

  Presenter: Julia Finkel, MD – Childrens National Hospital
• 4:55 PM - 5:15 PM US CT

  Cannabis Use in Pediatric Patients
  

  Presenter: Athena F. Zuppa, MD MSCE – Children's Hospital of Philadelphia
• 5:15 PM - 5:35 PM US CT

  FDA’s Efforts to Address Tobacco Use in Youth
  

  Presenter: Lisa M. Faulcon, MD – FDA/CTP/OS/DIHS
• 5:35 PM - 5:55 PM US CT

  Vaping: An Evolving Epidemic
  

  Presenter: Paul Moore, MD – Vanderbilt University Medical Center
• 5:55 PM - 6:00 PM US CT

  Co-chair : Concluding Remarks
  

  Presenter: Sonya Tang Girdwood, MD, PhD – Cincinnati Children's Hospital Medical Center
• 6:00 PM - 6:30 PM US CT

  Break
  

  Presenter: Belinda Thomas
• 6:30 PM - 7:00 PM US CT

  Click for Live Q&A: Dangerous Drug Epidemic: Opioids, Vaping, and Cannabis
  

  Presenter: Belinda Thomas